Literature DB >> 14563313

Induction of somatic hypermutation is associated with modifications in immunoglobulin variable region chromatin.

Caroline J Woo1, Alberto Martin, Matthew D Scharff.   

Abstract

Somatic hypermutation (SHM) requires selective targeting of the mutational machinery to the variable region of the immunoglobulin heavy chain gene. The induction of SHM in the BL2 cell line upon costimulation is associated with hyperacetylation of the chromatin at the variable region but not at the constant region. The V region-restricted histone hyperacetylation resulting from costimulation occurs independent of AID expression and mutation. Interestingly, costimulation in the presence of Trichostatin A causes hyperacetylation of histones associated with the constant region and extends mutations to the constant region. Under this condition, promoter proximal mutations are observed in the variable region as well. The overexpression of AID results in a similar deregulation of mutational targeting. Our results indicate that the stimulation of SHM in BL2 cells activates two independent pathways resulting in histone modifications that permit induced levels of AID to selectively target the variable region for mutation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563313     DOI: 10.1016/s1074-7613(03)00261-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  42 in total

1.  Genome-wide somatic hypermutation.

Authors:  Clifford L Wang; Ryan A Harper; Matthias Wabl
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-29       Impact factor: 11.205

2.  Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes.

Authors:  Lucia Kato; Nasim A Begum; A Maxwell Burroughs; Tomomitsu Doi; Jun Kawai; Carsten O Daub; Takahisa Kawaguchi; Fumihiko Matsuda; Yoshihide Hayashizaki; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 3.  Does DNA repair occur during somatic hypermutation?

Authors:  Huseyin Saribasak; Patricia J Gearhart
Journal:  Semin Immunol       Date:  2012-06-22       Impact factor: 11.130

4.  Differential regulation of histone acetylation and generation of mutations in switch regions is associated with Ig class switching.

Authors:  Ziqiang Li; Zhonghui Luo; Matthew D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-14       Impact factor: 11.205

Review 5.  Complex regulation and function of activation-induced cytidine deaminase.

Authors:  Janet Stavnezer
Journal:  Trends Immunol       Date:  2011-04-13       Impact factor: 16.687

6.  Activation-induced cytidine deaminase action is strongly stimulated by mutations of the THO complex.

Authors:  Belén Gómez-González; Andrés Aguilera
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-08       Impact factor: 11.205

Review 7.  AIDing antibody diversity by error-prone mismatch repair.

Authors:  Richard Chahwan; Winfried Edelmann; Matthew D Scharff; Sergio Roa
Journal:  Semin Immunol       Date:  2012-06-14       Impact factor: 11.130

8.  Overlapping hotspots in CDRs are critical sites for V region diversification.

Authors:  Lirong Wei; Richard Chahwan; Shanzhi Wang; Xiaohua Wang; Phuong T Pham; Myron F Goodman; Aviv Bergman; Matthew D Scharff; Thomas MacCarthy
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

9.  ADAR1 protein induces adenosine-targeted DNA mutations in senescent Bcl6 gene-deficient cells.

Authors:  Nobuhide Tsuruoka; Masafumi Arima; Nobuya Yoshida; Seiji Okada; Akemi Sakamoto; Masahiko Hatano; Hisae Satake; Eggi Arguni; Ji-Yang Wang; Jing-Hua Yang; Kazuko Nishikura; Souei Sekiya; Makio Shozu; Takeshi Tokuhisa
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

10.  Attracting AID to targets of somatic hypermutation.

Authors:  Atsushi Tanaka; Hong Ming Shen; Sarayu Ratnam; Prashant Kodgire; Ursula Storb
Journal:  J Exp Med       Date:  2010-01-25       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.